Search

Your search keyword '"Khan, Asaad"' showing total 185 results

Search Constraints

Start Over You searched for: Author "Khan, Asaad" Remove constraint Author: "Khan, Asaad"
185 results on '"Khan, Asaad"'

Search Results

1. Mapping of familial hypercholesterolemia and dyslipidemias basic management infrastructure in Pakistan: a cross-sectional study

5. Mapping of familial hypercholesterolemia and dyslipidemias basic management infrastructure in Pakistan: a cross-sectional study

16. Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiative

21. PROSTHESIS-PATIENT MISMATCH BETWEEN TRANSCATHETER HEART VALVES IN TRANSCATHETER AORTIC VALVE REPLACEMENT

24. TCT-833 Inflammatory Risk Status Is Age-Dependent in Women but Not in Men Undergoing Percutaneous Coronary Intervention

25. TCT-541 Validation of the Academic Research Consortium–High Bleeding Risk Criteria for Patients Undergoing Percutaneous Coronary Intervention

26. TCT-630 The Impact of Diabetes Mellitus in Patients Undergoing Percutaneous Coronary Intervention With a Drug Eluting Stent for Unprotected Left Main Stenosis

27. TCT-542 Impact of Baseline Anemia and Thrombocytopenia on 1-Year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention

29. TCT-838 Prognostic Value of High-Sensitivity C-Reactive Protein in Percutaneous Coronary Intervention According to Body Mass Index

31. TCT-834 Coronary Plaque Vulnerability in Statin Treated Patients With Elevated LDL-C and hs-CRP: Optical Coherence Tomography Study

32. TCT-689 Does Orienting Sapien 3 During Crimping in TAVR Affect Final Orientation to Coronaries to Impact TAV-in-TAV and Coronary Reaccess? A Pilot Study

33. TCT-18 Impact of Initial Evolut TAVR Deployment Orientation on Final Valve Orientation and Coronary Reaccess: A Pilot Study

35. TCT-757 Feasibility of Repeat Transcatheter Aortic Valve Replacement (TAVR) After SAPIEN 3 TAVR (TAV-in-TAV): A Pilot Angiographic Study

36. TCT-529 Novel Predictors New Persistent Left Bundle Branch Block After Evolut TAVR

37. TCT-635 Combined and Independent Impact of Diabetes Mellitus and Elevated C-Reactive Protein Levels on Risk for Death and MI Following PCI: Insights From a Large Single-Center Registry

38. TCT-662 Patients Who Do Not Receive Drug-Eluting Stent for In-Stent Restenosis: Characteristics and Outcomes

41. STENT EXPANSION AND ENDOTHELIAL SHEAR STRESS IN BIFURCATION LESION: COMPARISON OF KISSING BALLOON INFLATION AND PROXIMAL OPTIMIZING TECHNIQUE

42. SAFETY AND EFFICACY OF THE BIOABSORBABLE POLYMER EVEROLIMUS ELUTING STENTS COMPARED TO THE 2ND GENERATION DURABLE POLYMER EVEROLIMUS ELUTING STENTS IN COMPLEX CORONARY LESIONS

44. DOES ORIENTING SAPIEN3 DURING CRIMPING IN TAVR AFFECT FINAL ORIENTATION TO CORONARIES TO IMPACT CORONARY REACCESS? A PILOT STUDY

45. DOES VALVE CHOICE MATTER? A THEORETICAL MODEL COMPARING PROSTHESIS-PATIENT MISMATCH BETWEEN SAPIEN 3 AND EVOLUT R IN TRANSCATHETER AORTIC VALVE REPLACEMENT

46. SYNERGISTIC IMPACT OF CORONARY CALCIFICATION AND BIFURCATION TARGET LESIONS ON ADVERSE CARDIOVASCULAR EVENTS FOLLOWING PCI: INSIGHTS FROM A LARGE SINGLE-CENTER PCI REGISTRY

47. NOVEL PREDICTORS OF PERSISTENT LEFT BUNDLE BRANCH BLOCK AND PERMANENT PACEMAKER IMPLANTATION AFTER EDWARDS SAPIEN 3 TAVR

48. IMPACT OF INITIAL EVOLUT TAVR DEPLOYMENT ORIENTATION ON FINAL VALVE ORIENTATION AND CORONARY REACCESS: A PILOT STUDY

49. FEASIBILITY OF REPEAT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) AFTER SAPIEN 3 TAVR (TAV-IN-TAV): A PILOT ANGIOGRAPHIC STUDY

50. NOVEL PREDICTORS OF NEW PERSISTENT LEFT BUNDLE BRANCH BLOCK AND PERMANENT PACEMAKER IMPLANTATION AFTER EVOLUT R TAVR

Catalog

Books, media, physical & digital resources